Rifaximin is an effective alternative to metronidazole for the treatment of chronic enteropathy in dogs: a randomised trial

BACKGROUND: A clinical trial was conducted in order to assess the efficacy of rifaximin, a broad-spectrum antibiotic with negligible gastrointestinal absorption, in comparison with metronidazole, a commonly employed antimicrobial drug, in dogs with chronic enteropathy. Twenty-four pet dogs were rand...

Descripción completa

Detalles Bibliográficos
Autores principales: Menozzi, Alessandro, Dall’Aglio, Manuel, Quintavalla, Fausto, Dallavalle, Luca, Meucci, Valentina, Bertini, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053129/
https://www.ncbi.nlm.nih.gov/pubmed/27716258
http://dx.doi.org/10.1186/s12917-016-0851-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053129/
https://www.ncbi.nlm.nih.gov/pubmed/27716258
http://dx.doi.org/10.1186/s12917-016-0851-0

Ejemplares similares